Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Netting neutrophils in autoimmune small-vessel vasculitis
20091.3k citationsWolfgang L. Gross et al.profile →
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
2003902 citationsKirsten de Groot, Wolfgang L. Gross et al.profile →
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008618 citationsKirsten de Groot, Wolfgang L. Gross et al.profile →
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis
2005513 citationsKirsten de Groot, P A Bacon et al.Arthritis & Rheumatismprofile →
EULAR recommendations for the management of large vessel vasculitis
2008431 citationsKirsten de Groot, Wolfgang L. Gross et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Wolfgang L. Gross
Since
Specialization
Citations
This map shows the geographic impact of Wolfgang L. Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang L. Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang L. Gross more than expected).
Fields of papers citing papers by Wolfgang L. Gross
This network shows the impact of papers produced by Wolfgang L. Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang L. Gross. The network helps show where Wolfgang L. Gross may publish in the future.
Co-authorship network of co-authors of Wolfgang L. Gross
This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang L. Gross.
A scholar is included among the top collaborators of Wolfgang L. Gross based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Wolfgang L. Gross. Wolfgang L. Gross is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Gross, Wolfgang L.. (2020). CUADRO TECTÓNICO DEL VALLE DE PUNILLA. Revista de la Asociación Geológica Argentina. 3(2).
2.
Gross, Wolfgang L.. (2015). Die Neuregelung des Anlegerschutzes beim Delisting. 812–819.1 indexed citations
3.
Herrmann, Kristine, Wolfgang L. Gross, & Frank Moosig. (2012). Extended follow-up after stopping mepolizumab in relapsing/refractory Churg-Strauss syndrome.. PubMed. 30(1 Suppl 70). S62–5.47 indexed citations
Hellmich, Bernhard, Konstanze Holl‐Ulrich, Hartmut Merz, & Wolfgang L. Gross. (2008). Hypereosinophiles Syndrom und Churg-Strauss-Syndrom: Ist die Differenzierung der Syndrome klinisch relevant?. Der Internist. 49(3). 286–296.1 indexed citations
Ito, Satoshi, Wolfgang L. Gross, E. Reinhold‐Keller, et al.. (2006). Rheumatology in Japan, Germany, and Egypt : A Comparison of Medical Practices. 54(2). 51–58.8 indexed citations
14.
Gross, Wolfgang L.. (2006). Kapitalmarktrecht : Kommentar zum Börsengesetz, zur Börsenzulassungs- Verordnung, zum Wertpapierprospektgesetz und zum Verkaufsprospektgesetz. C.H.Beck eBooks.
15.
Groot, Kirsten de, N Rasmussen, P A Bacon, et al.. (2003). Randomized trial of cyclophosphamide versus methotrexate for induction of remission in "non-renal" AbCA-associated vasculitis.. Oxford University Research Archive (ORA) (University of Oxford). 48.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.